Assessing the Immunogenicity of 2 Subcutaneous Doses of CHS-1701 (Coherus Pegfilgrastim) With 2 Subcutaneous Doses Neulasta®
Clinical trial NCT02418104 · COMPLETED
Trial details
- NCT number
- NCT02418104
- Sponsor
- Coherus Oncology, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-01
- Primary completion
- 2015-12-01
- Enrollment
- 303
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.